TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY-0	putrescine degradation III	0.00217528045207941	-6.1305976792692	9	6	0.0348837209302326	172	907	4128,221,217,112483,224,6303	MAOA,ALDH3B1,ALDH2,SAT2,ALDH3A2,SAT1
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.0079400529422698	-4.83583533595316	8	5	0.0290697674418605	172	907	4122,4245,11320,4249,11282	MAN2A2,MGAT1,MGAT4A,MGAT5,MGAT4B
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.0295708883052009	-3.52096490481141	66	19	0.11046511627907	172	907	3636,90809,3635,5295,79837,10423,55300,23007,5335,5728,4952,5336,5290,5287,5293,9562,3706,200576,5330	INPPL1,TMEM55B,INPP5D,PIK3R1,PIP4K2C,CDIPT,PI4K2B,PLCH1,PLCG1,PTEN,OCRL,PLCG2,PIK3CA,PIK3C2B,PIK3CD,MINPP1,ITPKA,PIKFYVE,PLCB2
META_PWY-4041	gamma-glutamyl cycle	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	2730,2729	GCLM,GCLC
META_PWY-5340	sulfate activation for sulfonation	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	9060,9061	PAPSS2,PAPSS1
HUMAN_PWY-5340	sulfate activation for sulfonation	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	9060,9061	PAPSS2,PAPSS1
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	501,10157	ALDH7A1,AASS
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	55907,54187	CMAS,NANS
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.0357922559635492	-3.33002372284204	2	2	0.0116279069767442	172	907	501,10157	ALDH7A1,AASS
HUMAN_PWY-6402	superpathway of melatonin degradation	0.0400259847616087	-3.21822641673909	11	5	0.0290697674418605	172	907	4128,113612,5447,29785,1545	MAOA,CYP2U1,POR,CYP2S1,CYP1B1
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0471827264566566	-3.05372741827347	15	6	0.0348837209302326	172	907	337876,29940,64132,64131,55790,79586	CHSY3,DSE,XYLT2,XYLT1,CSGALNACT1,CHPF
META_PWY-6571	dermatan sulfate biosynthesis	0.0471827264566566	-3.05372741827347	15	6	0.0348837209302326	172	907	337876,29940,64132,64131,55790,79586	CHSY3,DSE,XYLT2,XYLT1,CSGALNACT1,CHPF
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.0471827264566566	-3.05372741827347	15	6	0.0348837209302326	172	907	3636,3706,9562,5728,4952,3635	INPPL1,ITPKA,MINPP1,PTEN,OCRL,INPP5D
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.0471827264566566	-3.05372741827347	15	6	0.0348837209302326	172	907	3636,3706,9562,5728,4952,3635	INPPL1,ITPKA,MINPP1,PTEN,OCRL,INPP5D
META_PWY-6566	chondroitin biosynthesis	0.0497833433699553	-3.00007482138208	5	3	0.0174418604651163	172	907	337876,55790,79586	CHSY3,CSGALNACT1,CHPF
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.0497833433699553	-3.00007482138208	5	3	0.0174418604651163	172	907	337876,55790,79586	CHSY3,CSGALNACT1,CHPF
META_PWY-6313	serotonin degradation	0.0497833433699553	-3.00007482138208	5	3	0.0174418604651163	172	907	4128,217,224	MAOA,ALDH2,ALDH3A2
META_PWY-6368	3-phosphoinositide degradation	0.0508681254451821	-2.9785187707344	19	7	0.0406976744186047	172	907	56623,3636,5728,4952,3635,90809,8821	INPP5E,INPPL1,PTEN,OCRL,INPP5D,TMEM55B,INPP4B
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.0508681254451821	-2.9785187707344	19	7	0.0406976744186047	172	907	3636,3706,9562,5728,4952,54928,3635	INPPL1,ITPKA,MINPP1,PTEN,OCRL,IMPAD1,INPP5D
META_PWY-6564	heparan sulfate biosynthesis	0.0523975352339822	-2.94889572628086	23	8	0.0465116279069767	172	907	9394,64132,64131,9953,2132,9348,26035,266722	HS6ST1,XYLT2,XYLT1,HS3ST3B1,EXT2,NDST3,GLCE,HS6ST3
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.0661209215595341	-2.71627006844444	20	7	0.0406976744186047	172	907	3636,3706,9562,5728,4952,54928,3635	INPPL1,ITPKA,MINPP1,PTEN,OCRL,IMPAD1,INPP5D
HUMAN_PWY-6368	3-phosphoinositide degradation	0.0661209215595341	-2.71627006844444	20	7	0.0406976744186047	172	907	56623,3636,5728,4952,3635,90809,8821	INPP5E,INPPL1,PTEN,OCRL,INPP5D,TMEM55B,INPP4B
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.0838135047315014	-2.4791611301642	17	6	0.0348837209302326	172	907	5335,23007,5330,90809,5336,79837	PLCG1,PLCH1,PLCB2,TMEM55B,PLCG2,PIP4K2C
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.0838135047315014	-2.4791611301642	17	6	0.0348837209302326	172	907	9394,9953,9348,2132,266722,26035	HS6ST1,HS3ST3B1,NDST3,EXT2,HS6ST3,GLCE
META_PWY-5327	superpathway of L-lysine degradation	0.0858922276985779	-2.45466193489374	6	3	0.0174418604651163	172	907	501,1428,10157	ALDH7A1,CRYM,AASS
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.0939299534951983	-2.36520595007646	3	2	0.0116279069767442	172	907	79152,224	FA2H,ALDH3A2
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.0939299534951983	-2.36520595007646	3	2	0.0116279069767442	172	907	2805,4190	GOT1,MDH1
META_PWY6666-2	dopamine degradation	0.0939299534951983	-2.36520595007646	3	2	0.0116279069767442	172	907	4128,224	MAOA,ALDH3A2
META_PWY-0	putrescine degradation III	0.0939299534951983	-2.36520595007646	3	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.0939299534951983	-2.36520595007646	3	2	0.0116279069767442	172	907	501,1428	ALDH7A1,CRYM
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.100214013275898	-2.30044724705702	26	8	0.0465116279069767	172	907	9394,64132,64131,9953,2132,9348,26035,266722	HS6ST1,XYLT2,XYLT1,HS3ST3B1,EXT2,NDST3,GLCE,HS6ST3
HUMAN_PWY-6398	melatonin degradation I	0.1021705485608	-2.28111181729466	10	4	0.0232558139534884	172	907	113612,5447,29785,1545	CYP2U1,POR,CYP2S1,CYP1B1
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.126668027284791	-2.06618557326548	23	7	0.0406976744186047	172	907	5335,23007,55300,10423,5330,5336,79837	PLCG1,PLCH1,PI4K2B,CDIPT,PLCB2,PLCG2,PIP4K2C
HUMAN_PWY66-221	nicotine degradation III	0.129896173306628	-2.04101981450295	7	3	0.0174418604651163	172	907	113612,29785,316	CYP2U1,CYP2S1,AOX1
HUMAN_PWY-6313	serotonin degradation	0.129896173306628	-2.04101981450295	7	3	0.0174418604651163	172	907	4128,217,224	MAOA,ALDH2,ALDH3A2
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.132461396225034	-2.02146402525132	19	6	0.0348837209302326	172	907	337876,64132,9435,64131,55790,79586	CHSY3,XYLT2,CHST2,XYLT1,CSGALNACT1,CHPF
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.16089302822472	-1.82701555578757	20	6	0.0348837209302326	172	907	9394,9953,9348,2132,266722,26035	HS6ST1,HS3ST3B1,NDST3,EXT2,HS6ST3,GLCE
META_PWY66-368	ketolysis	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	5019,622	OXCT1,BDH1
HUMAN_PWY6666-2	dopamine degradation	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	4128,224	MAOA,ALDH3A2
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-6117	spermine and spermidine degradation I	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	112483,6303	SAT2,SAT1
HUMAN_PWY66-368	ketolysis	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	5019,622	OXCT1,BDH1
META_PWY66-21	ethanol degradation II	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	124583,1503	CANT1,CTPS1
META_PWY66-162	ethanol degradation IV	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	1890,978	TYMP,CDA
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	6470,63826	SHMT1,SRR
META_PWY-6608	guanosine nucleotides degradation III	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	22978,7498	NT5C2,XDH
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	4190,2805	MDH1,GOT1
META_PWY66-161	oxidative ethanol degradation III	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-5874	heme degradation	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	644,645	BLVRA,BLVRB
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	8309,5447	ACOX2,POR
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.1647370386548	-1.80340478150288	4	2	0.0116279069767442	172	907	501,1428	ALDH7A1,CRYM
META_PWY-6352	3-phosphoinositide biosynthesis	0.178509560106313	-1.72311312117806	25	7	0.0406976744186047	172	907	5287,55300,5293,200576,10423,5295,5290	PIK3C2B,PI4K2B,PIK3CD,PIKFYVE,CDIPT,PIK3R1,PIK3CA
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.179933548790216	-1.71516766964089	8	3	0.0174418604651163	172	907	231,113612,29785	AKR1B1,CYP2U1,CYP2S1
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	10423	CDIPT
META_PWY-5329	L-cysteine degradation III	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	2805	GOT1
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	2805	GOT1
HUMAN_PWY-6399	melatonin degradation II	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	4128	MAOA
META_PWY66-389	phytol degradation	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	224	ALDH3A2
HUMAN_BGALACT-PWY	lactose degradation III	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	2720	GLB1
META_HISHP-PWY	L-histidine degradation VI	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	3034	HAL
META_PWY6666-1	anandamide degradation	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	2166	FAAH
HUMAN_PWY-5329	L-cysteine degradation II	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	2805	GOT1
HUMAN_PWY66-389	phytol degradation	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	224	ALDH3A2
META_PWY-6241	thyroid hormone biosynthesis	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	1509	CTSD
HUMAN_PWY-2161B	glutamate removal from folates	0.189636163175437	-1.66264797330098	1	1	0.00581395348837209	172	907	8836	GGH
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.220321991213525	-1.51266520621799	13	4	0.0232558139534884	172	907	337876,9435,55790,79586	CHSY3,CHST2,CSGALNACT1,CHPF
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.220321991213525	-1.51266520621799	13	4	0.0232558139534884	172	907	55300,10423,5330,5336	PI4K2B,CDIPT,PLCB2,PLCG2
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.234108237856923	-1.45197171562588	9	3	0.0174418604651163	172	907	5330,90809,5336	PLCB2,TMEM55B,PLCG2
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.237831568723253	-1.43619255028469	27	7	0.0406976744186047	172	907	5287,55300,5293,200576,10423,5295,5290	PIK3C2B,PI4K2B,PIK3CD,PIKFYVE,CDIPT,PIK3R1,PIK3CA
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	1633,978	DCK,CDA
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	6482,2650	ST3GAL1,GCNT1
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	1890,978	TYMP,CDA
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	5625,4942	PRODH,OAT
META_PWY-6398	melatonin degradation I	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	5447,1545	POR,CYP1B1
META_PWY-6402	superpathway of melatonin degradation	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	5447,1545	POR,CYP1B1
HUMAN_PWY66-21	ethanol degradation II	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-162	ethanol degradation IV	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	8566,250	PDXK,ALPP
HUMAN_PWY66-241	bupropion degradation	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	113612,29785	CYP2U1,CYP2S1
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	2584,130589	GALK1,GALM
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	2673,6675	GFPT1,UAP1
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	1633,978	DCK,CDA
HUMAN_PWY-5030	histidine degradation	0.241372835512243	-1.42141250559736	5	2	0.0116279069767442	172	907	144193,3034	AMDHD1,HAL
META_PWY-6569	chondroitin sulfate biosynthesis	0.243858197049739	-1.41116838225987	18	5	0.0290697674418605	172	907	337876,64132,64131,55790,79586	CHSY3,XYLT2,XYLT1,CSGALNACT1,CHPF
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	0.290652961841651	-1.23562529448019	10	3	0.0174418604651163	172	907	4128,217,224	MAOA,ALDH2,ALDH3A2
HUMAN_PWY66-201	nicotine degradation IV	0.290652961841651	-1.23562529448019	10	3	0.0174418604651163	172	907	113612,29785,316	CYP2U1,CYP2S1,AOX1
HUMAN_LIPASYN-PWY	phospholipases	0.302581930087549	-1.19540319491803	29	7	0.0406976744186047	172	907	5335,23007,5338,5337,11145,5330,5336	PLCG1,PLCH1,PLD2,PLD1,PLA2G16,PLCB2,PLCG2
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.312554259073838	-1.16297719584118	15	4	0.0232558139534884	172	907	3636,3706,4952,3635	INPPL1,ITPKA,OCRL,INPP5D
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.312554259073838	-1.16297719584118	15	4	0.0232558139534884	172	907	3636,3706,4952,3635	INPPL1,ITPKA,OCRL,INPP5D
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	2531,9517	KDSR,SPTLC2
META_PWY-6342	noradrenaline and adrenaline degradation	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
META_PWY3DJ-12	ceramide de novo biosynthesis	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	2531,9517	KDSR,SPTLC2
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	64132,64131	XYLT2,XYLT1
HUMAN_PWY66-161	oxidative ethanol degradation III	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	217,224	ALDH2,ALDH3A2
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	22978,7498	NT5C2,XDH
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	2531,9517	KDSR,SPTLC2
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.31911313941968	-1.14220957005027	6	2	0.0116279069767442	172	907	64132,64131	XYLT2,XYLT1
META_PWY-6076	vitamin D3 biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5447	POR
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	9562	MINPP1
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	501	ALDH7A1
HUMAN_PWY0-662	PRPP biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5634	PRPS2
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5447	POR
META_PWY-6117	spermine and spermidine degradation I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	6303	SAT1
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	978	CDA
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	4329	ALDH6A1
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	55312	RFK
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	54187	NANS
META_PWY-5874	heme degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	644	BLVRA
HUMAN_PWY6666-1	anandamide degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2166	FAAH
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	127253	TYW3
HUMAN_PWY-5905	hypusine biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	1725	DHPS
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	1509	CTSD
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	8566	PDXK
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2805	GOT1
META_PWY-5030	L-histidine degradation III	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	3034	HAL
HUMAN_PWY-5386	methylglyoxal degradation I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2739	GLO1
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	6470	SHMT1
HUMAN_PWY-4041	gamma-glutamyl cycle	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	26873	OPLAH
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2805	GOT1
META_PWY0-662	PRPP biosynthesis I	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5634	PRPS2
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5743	PTGS2
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	54187	NANS
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	224	ALDH3A2
META_PWY66-388	fatty acid alpha-oxidation III	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	224	ALDH3A2
META_PWY-5453	methylglyoxal degradation III	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	231	AKR1B1
META_PROUT-PWY	L-proline degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	5625	PRODH
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	6470	SHMT1
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	1632	ECI1
META_PWY-7343	UDP-glucose biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	7360	UGP2
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2805	GOT1
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	501	ALDH7A1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	2673	GFPT1
HUMAN_PWY-6608	guanosine nucleotides degradation	0.343480070381385	-1.06862618827108	2	1	0.00581395348837209	172	907	22978	NT5C2
META_PWY-5004	superpathway of L-citrulline metabolism	0.348017174579431	-1.0555034481857	11	3	0.0174418604651163	172	907	5625,4942,435	PRODH,OAT,ASL
META_LEU-DEG2-PWY	L-leucine degradation I	0.394799925865616	-0.929376159199889	7	2	0.0116279069767442	172	907	64087,56922	MCCC2,MCCC1
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.394799925865616	-0.929376159199889	7	2	0.0116279069767442	172	907	22978,57665	NT5C2,RDH14
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.394799925865616	-0.929376159199889	7	2	0.0116279069767442	172	907	501,6470	ALDH7A1,SHMT1
HUMAN_PWY-5067	glycogen biosynthesis	0.394799925865616	-0.929376159199889	7	2	0.0116279069767442	172	907	2997,7360	GYS1,UGP2
META_DETOX1-PWY-1	reactive oxygen species degradation	0.394799925865616	-0.929376159199889	7	2	0.0116279069767442	172	907	6647,6648	SOD1,SOD2
HUMAN_PWY-7511	protein ubiquitylation	0.443951499438363	-0.812039958015727	28	6	0.0348837209302326	172	907	55585,65264,92912,29089,55293,51465	UBE2Q1,UBE2Z,UBE2Q2,UBE2T,UEVLD,UBE2J1
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.460279610052186	-0.775921126224192	13	3	0.0174418604651163	172	907	3636,4952,54928	INPPL1,OCRL,IMPAD1
HUMAN_PWY-7434	terminal O-glycans residues modification	0.466422051557743	-0.762664364708169	8	2	0.0116279069767442	172	907	11041,8703	B4GAT1,B4GALT3
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.466422051557743	-0.762664364708169	8	2	0.0116279069767442	172	907	6675,10007	UAP1,GNPDA1
HUMAN_PWY-5331	taurine biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	84890	ADO
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	6697	SPR
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	978	CDA
META_PWY-5331	taurine biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	84890	ADO
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	4942	OAT
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9562	MINPP1
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	978	CDA
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	2805	GOT1
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9415	FADS2
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9415	FADS2
META_PWY-6875	retinoate biosynthesis II	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	7498	XDH
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	1503	CTPS1
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9562	MINPP1
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	4942	OAT
HUMAN_PWY0-1182	trehalose degradation	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	130589	GALM
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	231	AKR1B1
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	6697	SPR
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	6697	SPR
META_PWY-2301	myo-inositol biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	54928	IMPAD1
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	978	CDA
META_PWY-7177	UTP and CTP dephosphorylation II	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	1503	CTPS1
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	2235	FECH
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9415	FADS2
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	10007	GNPDA1
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	4942	OAT
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	231	AKR1B1
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	2235	FECH
HUMAN_PWY-5453	methylglyoxal degradation III	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	231	AKR1B1
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	32	ACACB
META_PWY66-221	nicotine degradation V	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	316	AOX1
HUMAN_PWY-7283	wybutosine biosynthesis	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	127253	TYW3
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	9415	FADS2
META_PWY-7185	UTP and CTP dephosphorylation I	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	1503	CTPS1
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.468255128831297	-0.758741984527755	3	1	0.00581395348837209	172	907	130589	GALM
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.473360946674786	-0.747897080711216	34	7	0.0406976744186047	172	907	4128,217,113612,224,5447,29785,1545	MAOA,ALDH2,CYP2U1,ALDH3A2,POR,CYP2S1,CYP1B1
HUMAN_PWY-4061	glutathione-mediated detoxification	0.499916121167552	-0.693314952297732	19	4	0.0232558139534884	172	907	56267,8836,4258,2950	CCBL2,GGH,MGST2,GSTP1
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.528907424619138	-0.636941863158216	25	5	0.0290697674418605	172	907	2591,51809,6482,79695,2650	GALNT3,GALNT7,ST3GAL1,GALNT12,GCNT1
HUMAN_PWY-6353	purine nucleotides degradation	0.532797426902027	-0.629613989155706	9	2	0.0116279069767442	172	907	22978,57665	NT5C2,RDH14
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.532797426902027	-0.629613989155706	9	2	0.0116279069767442	172	907	427,81537	ASAH1,SGPP1
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.532797426902027	-0.629613989155706	9	2	0.0116279069767442	172	907	22978,7498	NT5C2,XDH
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.563550664721206	-0.573498038769936	15	3	0.0174418604651163	172	907	5315,2026,5211	PKM,ENO2,PFKL
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.563550664721206	-0.573498038769936	15	3	0.0174418604651163	172	907	129607,1633,978	CMPK2,DCK,CDA
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	5208	PFKFB2
META_PWY-7434	terminal O-glycans residues modification	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	11041	B4GAT1
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	9562	MINPP1
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	51074	APIP
HUMAN_PWY-2161	folate polyglutamylation	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	6470	SHMT1
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	1737	DLAT
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	29940	DSE
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	2805	GOT1
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	2997	GYS1
HUMAN_PWY66-367	ketogenesis	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	622	BDH1
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	51074	APIP
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	5208	PFKFB2
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	224	ALDH3A2
HUMAN_PWY-4984	urea cycle	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	435	ASL
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	29940	DSE
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	2950	GSTP1
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	224	ALDH3A2
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	10007	GNPDA1
META_PWY66-387	fatty acid alpha-oxidation II	0.569427825559464	-0.563123237121	4	1	0.00581395348837209	172	907	224	ALDH3A2
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.593333543168467	-0.521998570709459	10	2	0.0116279069767442	172	907	6647,6648	SOD1,SOD2
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.593333543168467	-0.521998570709459	10	2	0.0116279069767442	172	907	1633,978	DCK,CDA
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.647848291743692	-0.434098727719173	11	2	0.0116279069767442	172	907	4952,54928	OCRL,IMPAD1
HUMAN_LEU-DEG2-PWY	leucine degradation	0.647848291743692	-0.434098727719173	11	2	0.0116279069767442	172	907	64087,56922	MCCC2,MCCC1
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.647848291743692	-0.434098727719173	11	2	0.0116279069767442	172	907	26090,57104	ABHD12,PNPLA2
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.647848291743692	-0.434098727719173	11	2	0.0116279069767442	172	907	129607,1503	CMPK2,CTPS1
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	10555	AGPAT2
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	435	ASL
HUMAN_PWY66-375	leukotriene biosynthesis	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	4048	LTA4H
HUMAN_PWY-3661-1	glycine betaine degradation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	6470	SHMT1
META_PWY66-375	leukotriene biosynthesis	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	4048	LTA4H
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	53354	PANK1
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	221	ALDH3B1
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	6470	SHMT1
META_PWY-6111	mitochondrial L-carnitine shuttle	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	1376	CPT2
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	2184	FAH
META_PWY66-367	ketogenesis	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	622	BDH1
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	7498	XDH
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	55500	ETNK1
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	2184	FAH
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	1737	DLAT
META_PWY-6074	zymosterol biosynthesis	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	3930	LBR
META_PWY-4983	L-citrulline-nitric oxide cycle	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	435	ASL
META_PWY66-201	nicotine degradation IV	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	316	AOX1
META_PWY-4061	glutathione-mediated detoxification I	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	56267	CCBL2
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	53354	PANK1
META_PWY-4984	urea cycle	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	435	ASL
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	1376	CPT2
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	978	CDA
META_PWY-4081	glutathione redox reactions I	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	2879	GPX4
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	22978	NT5C2
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.651441573073565	-0.428567567062629	5	1	0.00581395348837209	172	907	32	ACACB
META_PWY66-400	glycolysis VI (metazoan)	0.6539769271586	-0.424683207721284	17	3	0.0174418604651163	172	907	5315,2026,5211	PKM,ENO2,PFKL
HUMAN_PWY66-400	glycolysis	0.6539769271586	-0.424683207721284	17	3	0.0174418604651163	172	907	5315,2026,5211	PKM,ENO2,PFKL
HUMAN_VALDEG-PWY	valine degradation	0.696436995106607	-0.361777949140962	12	2	0.0116279069767442	172	907	27034,4329	ACAD8,ALDH6A1
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.696436995106607	-0.361777949140962	12	2	0.0116279069767442	172	907	8309,5447	ACOX2,POR
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	130589	GALM
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	56994	CHPT1
HUMAN_PWY-5996	oleate biosynthesis	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	79966	SCD5
HUMAN_PWY-6074	zymosterol biosynthesis	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	3930	LBR
META_PWY-7176	UTP and CTP de novo biosynthesis	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	1503	CTPS1
HUMAN_PWY-4081	glutathione redox reactions I	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	2879	GPX4
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.717907259806601	-0.331414882891143	6	1	0.00581395348837209	172	907	978	CDA
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.728666846910973	-0.316538651551982	25	4	0.0232558139534884	172	907	10555,9890,8613,84649	AGPAT2,PLPPR4,PLPP3,DGAT2
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.730266437326617	-0.31434582879046	19	3	0.0174418604651163	172	907	8760,10555,1040	CDS2,AGPAT2,CDS1
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.730266437326617	-0.31434582879046	19	3	0.0174418604651163	172	907	205,122481,10476	AK4,AK7,ATP5H
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.739374701481482	-0.301950447993971	13	2	0.0116279069767442	172	907	129607,1503	CMPK2,CTPS1
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	2235	FECH
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	142891	SAMD8
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	5743	PTGS2
META_PWY-6872	retinoate biosynthesis I	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	220	ALDH1A3
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	1503	CTPS1
META_PWY-7224	purine deoxyribonucleosides salvage	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	1633	DCK
META_PWY66-374	C20 prostanoid biosynthesis	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	5743	PTGS2
HUMAN_PWY-5920	heme biosynthesis	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	2235	FECH
HUMAN_PWY66-373	sucrose degradation	0.771758482132463	-0.259083624882861	7	1	0.00581395348837209	172	907	130589	GALM
HUMAN_PWY-2201	folate transformations I	0.815377972216267	-0.204103503658641	8	1	0.00581395348837209	172	907	6470	SHMT1
HUMAN_PWY-6872	retinoate biosynthesis I	0.815377972216267	-0.204103503658641	8	1	0.00581395348837209	172	907	220	ALDH1A3
HUMAN_PWY66-399	gluconeogenesis	0.838375107661638	-0.176289656145202	16	2	0.0116279069767442	172	907	4190,2026	MDH1,ENO2
META_PWY66-399	gluconeogenesis III	0.838375107661638	-0.176289656145202	16	2	0.0116279069767442	172	907	4190,2026	MDH1,ENO2
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.850700540383397	-0.161695103778451	9	1	0.00581395348837209	172	907	79868	ALG13
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	0.850700540383397	-0.161695103778451	9	1	0.00581395348837209	172	907	56267	CCBL2
HUMAN_PWY-7205	CMP phosphorylation	0.850700540383397	-0.161695103778451	9	1	0.00581395348837209	172	907	129607	CMPK2
HUMAN_PWY-7527	methionine salvage cycle III	0.850700540383397	-0.161695103778451	9	1	0.00581395348837209	172	907	51074	APIP
HUMAN_PWY-6857	retinol biosynthesis	0.862961531730472	-0.147385163943802	17	2	0.0116279069767442	172	907	8824,9249	CES2,DHRS3
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.877308416525809	-0.130896676224823	38	5	0.0290697674418605	172	907	4190,5315,2026,5211,1737	MDH1,PKM,ENO2,PFKL,DLAT
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.879296873409706	-0.128632698375473	10	1	0.00581395348837209	172	907	9415	FADS2
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.879296873409706	-0.128632698375473	10	1	0.00581395348837209	172	907	129607	CMPK2
META_PWY66-341	cholesterol biosynthesis I	0.902441731576877	-0.102651154209125	11	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY-6309	L-kynurenine degradation	0.902441731576877	-0.102651154209125	11	1	0.00581395348837209	172	907	56267	CCBL2
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.902441731576877	-0.102651154209125	11	1	0.00581395348837209	172	907	3930	LBR
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.902441731576877	-0.102651154209125	11	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.902441731576877	-0.102651154209125	11	1	0.00581395348837209	172	907	1633	DCK
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.917638050043884	-0.0859522471087838	20	2	0.0116279069767442	172	907	129607,1503	CMPK2,CTPS1
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.921169434894832	-0.0821112912486433	12	1	0.00581395348837209	172	907	8309	ACOX2
META_PWY-6857	retinol biosynthesis	0.921169434894832	-0.0821112912486433	12	1	0.00581395348837209	172	907	9249	DHRS3
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.921169434894832	-0.0821112912486433	12	1	0.00581395348837209	172	907	36	ACADSB
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.921169434894832	-0.0821112912486433	12	1	0.00581395348837209	172	907	9415	FADS2
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	1503	CTPS1
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY66-341	cholesterol biosynthesis I	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	3930	LBR
META_PWY-6861	the visual cycle I (vertebrates)	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	9249	DHRS3
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.936318996014661	-0.0657990528583296	13	1	0.00581395348837209	172	907	8309	ACOX2
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.948570822288624	-0.0527988247207337	14	1	0.00581395348837209	172	907	1632	ECI1
HUMAN_PWY-5328	superpathway of methionine degradation	0.948570822288624	-0.0527988247207337	14	1	0.00581395348837209	172	907	2805	GOT1
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.948570822288624	-0.0527988247207337	14	1	0.00581395348837209	172	907	2805	GOT1
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.958476554171401	-0.0424101777539833	15	1	0.00581395348837209	172	907	9249	DHRS3
META_PWY66-398	TCA cycle III (animals)	0.966483317272834	-0.0340912414523726	16	1	0.00581395348837209	172	907	4190	MDH1
HUMAN_PWY66-398	TCA cycle	0.966483317272834	-0.0340912414523726	16	1	0.00581395348837209	172	907	4190	MDH1
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.982445554019585	-0.0177103525303779	37	3	0.0174418604651163	172	907	205,122481,10476	AK4,AK7,ATP5H
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.985184439778888	-0.0149264068323765	38	3	0.0174418604651163	172	907	205,122481,10476	AK4,AK7,ATP5H
META_PWY66-5	superpathway of cholesterol biosynthesis	0.992573960189811	-0.00745375011426754	23	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.995183917722315	-0.00482771697273497	25	1	0.00581395348837209	172	907	3930	LBR
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6620	guanine and guanosine salvage	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY66-397	resolvin D biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-7511	protein ubiquitylation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6181	histamine degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_SERDEG-PWY	L-serine degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-5670	epoxysqualene biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY-6181	histamine degradation	0.999999999993568	-6.43167463731942e-12	2	0	0	172	907
META_PWY66-382	mineralocorticoid biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-6609	adenine and adenosine salvage III	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_GLYCLEAV-PWY	glycine cleavage	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY66-392	lipoxin biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-6875	retinoate biosynthesis II	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-6430	thymine degradation	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY66-381	glucocorticoid biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY66-301	catecholamine biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-6100	L-carnitine biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY0-1296	purine ribonucleosides degradation	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-3982	uracil degradation	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-6100	L-carnitine biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-7527	L-methionine salvage cycle III	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY-6609	adenine and adenosine salvage III	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-3982	uracil degradation I (reductive)	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_GLUDEG-I-PWY	GABA shunt	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
HUMAN_PWY66-392	lipoxin biosynthesis	0.999999999998229	-1.77129578365909e-12	3	0	0	172	907
META_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-7205	CMP phosphorylation	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-3781	aerobic respiration I (cytochrome c)	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5177	glutaryl-CoA degradation	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-6292	cysteine biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-4921	protein citrullination	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5661	GDP-glucose biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-4261	glycerol degradation	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999336	-6.6425359136757e-13	4	0	0	172	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY66-421	homocarnosine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_P121-PWY	adenine and adenosine salvage I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5686	UMP biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5905	hypusine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5966	fatty acid biosynthesis initiation II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-46	putrescine biosynthesis III	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6898	thiamin salvage III	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6132	lanosterol biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY0-522	lipoate salvage	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6377	alpha-tocopherol degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_GLYCGREAT-PWY	creatine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5326	sulfite oxidation IV	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_GLUT-REDOX-PWY	glutathione redox reactions II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-40	putrescine biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7506	phosphatidylserine biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6938	NADH repair	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PROUT-PWY	proline degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7299	progesterone biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5326	sulfite oxidation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY0-1305	glutamate dependent acid resistance	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_GLNSYN-PWY	L-glutamine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-4101	sorbitol degradation I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_SERDEG-PWY	L-serine degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-40	putrescine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7306	estradiol biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-7299	progesterone biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6619	adenine and adenosine salvage VI	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-421	homocarnosine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7592	arachidonate biosynthesis III (metazoa)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5766	L-glutamate degradation X	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6173	histamine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY66-241	bupropion degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-366	flavin biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-420	carnosine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7344	UDP-D-galactose biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_ARGSPECAT-PWY	spermine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6938	NADH repair	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7501	phosphatidylserine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6132	lanosterol biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY66-420	carnosine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-46	putrescine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_MANNCAT-PWY	D-mannose degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6535	4-aminobutyrate degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6173	histamine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6481	L-dopachrome biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6377	alpha-tocopherol degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY0-1021	L-alanine biosynthesis III	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6134	L-tyrosine biosynthesis IV	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_GLNSYN-PWY	glutamine biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-5269	cardiolipin biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6535	4-aminobutanoate degradation I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6619	adenine and adenosine salvage II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY-6334	L-dopa degradation	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-11	BMP Signalling Pathway	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
META_PWY-6133	(S)-reticuline biosynthesis II	0.999999999999561	-4.38815650483093e-13	1	0	0	172	907
HUMAN_PWY66-380	estradiol biosynthesis I	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_VALDEG-PWY	L-valine degradation I	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-4921	protein citrullination	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000105	1.04979629047923e-12	5	0	0	172	907
META_PWY66-428	L-threonine degradation V	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_PWY-5972	stearate biosynthesis I (animals and fungi)	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_PWY66-378	androgen biosynthesis	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PWY-5143	fatty acid activation	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_ILEUDEG-PWY	L-isoleucine degradation I	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PWY66-428	threonine degradation	1.00000000000294	2.93987516351412e-12	6	0	0	172	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
META_PWY-5130	2-oxobutanoate degradation I	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
META_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
HUMAN_PWY-5130	2-oxobutanoate degradation	1.00000000000516	5.15515944480584e-12	7	0	0	172	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000663	6.62787539690913e-12	8	0	0	172	907
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000663	6.62787539690913e-12	8	0	0	172	907
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	1.00000000000663	6.62787539690913e-12	8	0	0	172	907
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000918	9.18440168410945e-12	9	0	0	172	907
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	1.00000000000918	9.18440168410945e-12	9	0	0	172	907
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000918	9.18440168410945e-12	9	0	0	172	907
META_PWY-922	mevalonate pathway I	1.00000000001143	1.1428255883912e-11	10	0	0	172	907
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000001143	1.1428255883912e-11	10	0	0	172	907
HUMAN_PWY-922	mevalonate pathway	1.00000000001143	1.1428255883912e-11	10	0	0	172	907
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.00000000001143	1.1428255883912e-11	10	0	0	172	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001192	1.19196633776814e-11	11	0	0	172	907
HUMAN_PWY-5972	stearate biosynthesis	1.00000000001192	1.19196633776814e-11	11	0	0	172	907
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000001192	1.19196633776814e-11	11	0	0	172	907
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	1.00000000001192	1.19196633776814e-11	11	0	0	172	907
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000001421	1.42125920584977e-11	12	0	0	172	907
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000001421	1.42125920584977e-11	12	0	0	172	907
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	1.00000000001613	1.61323890480493e-11	13	0	0	172	907
META_PWY66-409	superpathway of purine nucleotide salvage	1.00000000001613	1.61323890480493e-11	13	0	0	172	907
META_FAO-PWY	fatty acid beta-oxidation I	1.00000000001682	1.68217007996381e-11	14	0	0	172	907
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000001682	1.68217007996381e-11	14	0	0	172	907
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	1.00000000001682	1.68217007996381e-11	14	0	0	172	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001682	1.68217007996381e-11	14	0	0	172	907
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000001682	1.68217007996381e-11	14	0	0	172	907
